Literature DB >> 23355933

Successful colonoscopic approach in a child with intussusception associated with enterohemorrhagic Escherichia coli O157 infection.

Shin-Ichiro Hagiwara1, Hisako Tobayama, Seiichi Kagimoto.   

Abstract

The pathogenesis of intussusception caused by enterohemorrhagic Escherichia coli (E. coli) O157 infection is unknown. In our case, colonoscopy was useful for confirming O157 infection. The intussusception was caused by focally damaged edematous mucosa in the cecum. This case helped in elucidating the pathogenesis of the disease.

Entities:  

Keywords:  O157.; colonoscopy; intussusception

Year:  2012        PMID: 23355933      PMCID: PMC3555203          DOI: 10.4081/pr.2012.e33

Source DB:  PubMed          Journal:  Pediatr Rep        ISSN: 2036-749X


  4 in total

1.  Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.

Authors:  H Fukushima; T Hashizume; Y Morita; J Tanaka; K Azuma; Y Mizumoto; M Kaneno; M Matsuura; K Konma; T Kitani
Journal:  Pediatr Int       Date:  1999-04       Impact factor: 1.524

2.  Intussusception associated with Escherichia coli O157:H7.

Authors:  E L Lopez; S Devoto; M Woloj; L K Pickering; T G Cleary
Journal:  Pediatr Infect Dis J       Date:  1989-07       Impact factor: 2.129

Review 3.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

Review 4.  Enterohaemorrhagic Escherichia coli in human medicine.

Authors:  Helge Karch; Phillip I Tarr; Martina Bielaszewska
Journal:  Int J Med Microbiol       Date:  2005-10       Impact factor: 3.473

  4 in total
  1 in total

Review 1.  Enterohemorrhagic Escherichia coli and a Fresh View on Shiga Toxin-Binding Glycosphingolipids of Primary Human Kidney and Colon Epithelial Cells and Their Toxin Susceptibility.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.